Johnson & Johnson (JNJ) Holder Adage Capital Partners Gp LLC Increased Holding by $5.75 Million

January 21, 2018 - By Nellie Frank

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It has no change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Cubist Systematic Strategies Ltd has 47,949 shares for 0.35% of their portfolio. 67,216 are held by Taurus Asset Management Ltd Liability Co. Pinnacle Partners holds 81,215 shares. Eastern Bancshares holds 1.66% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 179,780 shares. Schaller Gru Incorporated invested 0.19% of its portfolio in Johnson & Johnson (NYSE:JNJ). 9,315 were accumulated by Lehman. Stanley reported 0.28% of its portfolio in Johnson & Johnson (NYSE:JNJ). Roundview Cap Limited Liability Com holds 1.84% in Johnson & Johnson (NYSE:JNJ) or 47,645 shares. Savings Bank Pictet & Cie (Asia) Limited has 77,500 shares for 4.75% of their portfolio. Beddow Capital Mgmt Inc reported 4.01% in Johnson & Johnson (NYSE:JNJ). Kentucky Retirement System Ins Fund holds 1.64% or 71,231 shares. Moreover, Merriman Wealth Limited Liability Com has 0.27% invested in Johnson & Johnson (NYSE:JNJ) for 8,593 shares. Continental Advisors Ltd Llc owns 7,300 shares. Ameriprise holds 17.50 million shares or 1.08% of its portfolio. Axel Ltd Liability Corp holds 0.63% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 7,400 shares.

Phill Gross increased its stake in Johnson & Johnson (JNJ) by 1.2% based on its latest 2017Q3 regulatory filing with the SEC. Adage Capital Partners Gp Llc bought 44,230 shares as the company’s stock rose 6.85% with the market. The hedge fund run by Phill Gross held 3.72M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $483.84M, up from 3.68 million at the end of the previous reported quarter. Adage Capital Partners Gp Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $395.89B market cap company. The stock increased 0.30% or $0.44 during the last trading session, reaching $147.36. About 8.74M shares traded or 58.03% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 21, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Adage Capital Partners Gp Llc, which manages about $41.15 billion US Long portfolio, decreased its stake in Newmont Mining Corp (NYSE:NEM) by 257,900 shares to 750,800 shares, valued at $28.16M in 2017Q3, according to the filing. It also reduced its holding in Ringcentral Inc (NYSE:RNG) by 785,000 shares in the quarter, leaving it with 190,000 shares, and cut its stake in Hologic Inc (NASDAQ:HOLX).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Fool.com which released: “Is Johnson & Johnson a Buy?” on January 16, 2018, also Cnbc.com with their article: “J&J attracts Chinese interest for diabetes business in potential $3B to $4B …” published on January 17, 2018, Seekingalpha.com published: “Johnson & Johnson: A Good Value In This Overheated Market” on January 08, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Realmoney.Thestreet.com and their article: “No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble” published on January 17, 2018 as well as Prnewswire.com‘s news article titled: “Johnson & Johnson Issues Statement on ZYTIGA® Inter Partes Reviews” with publication date: January 17, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. UBS maintained the stock with “Buy” rating in Wednesday, October 19 report. The rating was downgraded by Alembic to “Underweight” on Friday, July 21. The company was maintained on Friday, July 14 by Jefferies. The firm has “Overweight” rating given on Monday, May 15 by JP Morgan. The rating was maintained by Citigroup with “Buy” on Monday, October 23. The firm has “Buy” rating by Cowen & Co given on Thursday, August 24. The firm has “Hold” rating given on Wednesday, April 6 by Societe Generale. As per Monday, August 31, the company rating was downgraded by Vetr. The company was maintained on Friday, September 22 by RBC Capital Markets. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, October 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: